Fosun Pharma Industrial Pte.Ltd. increases its stake in SISRAM MED (01696) by approximately 335 million shares at a price of HK$3.34 per share.
After the increase, the latest number of shares held is approximately 334 million, and the latest shareholding ratio is 71.42%.
According to the latest information from the Hong Kong Stock Exchange, on April 8th, Fosun Pharma Industrial Pte. Ltd. increased its holdings of Sisram Medical (01696) by 334.5048 million shares, with a price of 3.34 Hong Kong dollars per share, for a total amount of approximately 1.117 billion Hong Kong dollars. After the increase, the total number of shares held is approximately 334 million, with a new holding percentage of 71.42%.
Additional information: On 8 April 2026, Ample Up Limited and Chindex Medical Limited entered into share transfer agreements with Fosun Pharma Industrial Pte. Ltd. Ample Up and Chindex agreed to transfer their entire holdings of 207,186,160 shares and 127,318,640 shares of Sisram Medical Ltd to FPI. For further details, please refer to Sisram Medical Ltd's announcement on April 8, 2026.
Related Articles
.png)
US Stock Market Move | ASE Technology Holding Co., Ltd. Sponsored ADR (ASX.US) rose more than 5%, investing over 100 billion New Taiwan dollars to build a high-end testing facility.
Chongqing Polycomp International Corporation (301526.SZ) shareholder Yunnan Yunxi plans to reduce its shareholding by no more than 4%.
MEITUAN-W (03690) granted a total of approximately 79.31 million shares of reward shares.
US Stock Market Move | ASE Technology Holding Co., Ltd. Sponsored ADR (ASX.US) rose more than 5%, investing over 100 billion New Taiwan dollars to build a high-end testing facility.
Chongqing Polycomp International Corporation (301526.SZ) shareholder Yunnan Yunxi plans to reduce its shareholding by no more than 4%.
MEITUAN-W (03690) granted a total of approximately 79.31 million shares of reward shares.
RECOMMEND
